Investing in Cytodyn

Quote: Mission146

I just like to look at the paper and pick the company whose name I like the best.

Oh wait, that's something else.

That is how horse racing works for me.

Well let me stand corrected that when I said following stocks you aren't invested in I actually meant posting updates on them highlighting only when they go down in price.

Is that something you do Bill?

Follow stocks you are not invested in and post whenever they go down?

EDIT: And yes I know you do that with Bitcoin but that's a horse of a different color

Quote: darkoz

Quote: MDawg

Looks like it is heading back down again.

Sorry, I missed the post when you said it went up.

Oh, wait, you don't post when Cytodyn goes up. Only when it goes down.

Now, why is that?

What is your interest again?

EDIT:. Price always seems to go down on good news with Cytodyn. Crazy world or shorting?

https://riotimesonline.com/brazil-news/brazil/brazils-health-regulator-authorizes-biomm-to-conduct-phase-3-trials-of-anti-covid-drug/#0

Are you trying to get him to admit the obvious, that he is trolling you?

You have a better chance of watching Cytodyn go to the moon.

Thanks to DO's incessant hawking of the stock, several members bought it. Only a few weeks ago he was lauding it again.

Quote: darkoz

Well let me stand corrected that when I said following stocks you aren't invested in I actually meant posting updates on them highlighting only when they go down in price.

Is that something you do Bill?

Follow stocks you are not invested in and post whenever they go down?

EDIT: And yes I know you do that with Bitcoin but that's a horse of a different color

I post about bitcoin when I see something I think will be of interest. Made a post about it today and I don't think it is down substantially

Quote: billryan

Thanks to DO's incessant hawking of the stock, several members bought it. Only a few weeks ago he was lauding it again.

Caveat emptor. You know that.

Quote: billryan

Thanks to DO's incessant hawking of the stock, several members bought it. Only a few weeks ago he was lauding it again.

I'm still lauding it.

Price action means nothing as it's a biotech stock going through trials.

Which is why I haven't sold a single share.

Biotech stock takes years to show good results and nothing is guaranteed.

Except the stock won't fly to the moon until drug approval

Quote: billryan

Thanks to DO's incessant hawking of the stock, several members bought it. Only a few weeks ago he was lauding it again.

Thanks to them hitting the BUY button, they bought it. Wise investors and traders shouldn’t even base their decisions on stock message boards, much less stock threads on non-stock message boards.

If it was good enough to hawk then, it should be fine to hawk it now. Keep hope alive!

This is the MDawg investment thread, but he mentioned CYDY so I will jump in. I bought $1600 worth. The most likely result is at some point it will be worth $0. I am well aware of the risk involved, but as I’ve stated many times hitting one 10 bagger more than makes up for 4 bankrupt ones. I think I’ll only remind the forum of the penny stock that I bought, GLXZ, at $0.24, now selling at almost 20 times that!

MDawg touts buying and holding blue chip type stocks, and he specifically mentions AMZN, TSLA, and a few others.

There is nothing that would say EITHER MDawg or darkoz is wrong in their approach, as each has different goals and risk tolerances.

Please don't claim I am saying that Cassava Science situation IS going to happen to Cytodyn.

Only trial results will tell and I am not a fortune teller.

I'm saying this is the gamble and this is the way biotech working on new drugs can look. Biotech has plenty of failure but if you get the drug approval then Cassava Science is a good example of why people invest in Biotech.

Trading at around $1 for years.

And for those like Bill Ryan who keep pointing to the "lawsuits against Cytodyn" they aren't lawsuits.

Those are INVESTIGATIONS trying to either ambulance chase or help short sellers depress the stock and are simply bogus

Here is just one law firm that actually ran investigations into Cytodyn also launching an investigation in Cassava Science.

https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-cassava-sciences-inc---sava-301347716.html

How many forum members think a stock that rose from $1 to $101 is going to be actually sued by investors?

And yes, that was released this week

Quote: darkoz

And for those like Bill Ryan who keep pointing to the "lawsuits against Cytodyn" they aren't lawsuits.

Those are INVESTIGATIONS trying to either ambulance chase or help short sellers depress the stock and are simply bogus

Here is just one law firm that actually ran investigations into Cytodyn also launching an investigation in Cassava Science.

https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-cassava-sciences-inc---sava-301347716.html

How many forum members think a stock that rose from $1 to $101 is going to be actually sued by investors?

And yes, that was released this week

Are you saying there are no stockholder lawsuits against the company for misrepresentation and fraud?

Quote: billryan

Are you saying there are no stockholder lawsuits against the company for misrepresentation and fraud?

No, There are some. I don't see any merit in the lawsuits and I suspect they aren't going anywhere.

My point is those law firms are ambulance chasing.

By the time those are settled (years from now) the Leronlimab trials will be over and the stock price will hopefully have soared. Anyone who sold at a loss and is suing is just a bad investor.

BTW, is it your opinion that shareholders get to sue for their money back if a company stock price goes down?

Quote: darkoz

No, There are some. I don't see any merit in the lawsuits and I suspect they aren't going anywhere.

My point is those law firms are ambulance chasing.

By the time those are settled (years from now) the Leronlimab trials will be over and the stock price will hopefully have soared. Anyone who sold at a loss and is suing is just a bad investor.

BTW, is it your opinion that shareholders get to sue for their money back if a company stock price goes down?

No, but when the company misrepresents facts like these guys did, not only should they be sued , but they may well need to be prosecuted. Those press releases you kept posting were full of obvious lies. Their trials would be a total failure and they put out a release pushing some minor part of the trial that succeeded. That is not how legit companies operate. I've lost money on hundreds of companies, and lost 85% plus on more than a few, but only joined lawsuits against two of them and in both cases, people went to jail. When a company takes investor money, they have a fiduciary responsibility to them. They don't have to make you money, but they have to be upfront with you.

Did the ambulance chasing lawyers get half of the former board to sue the company?

On April 24, 2020, certain stockholders of CytoDyn Inc. (the “Company), including two former directors and a company controlled by a former director (Anthony D. Caracciolo of the Caracciolo Family Trust, Gregory A. Gould, and Alpha Venture Capital Partners L.P., controlled by Carl C. Dockery, respectively), filed a derivative stockholder complaint in the Court of Chancery of the State of Delaware, alleging claims for breach of fiduciary duty and unjust enrichment against the Company’s CEO, current and former CFO, CMO, and current and former members of the Company’s board of directors in connection with certain equity grant awards to these individuals in December 2019 and January 2020. The Company disclosed these awards in the Company’s Current Reports on Form 8-K filed with the U.S. Securities and Exchange Commission on December 27, 2019 and February 3, 2020. The Company was named as a nominal defendant. The plaintiffs seek the rescission of the awards, a finding that the named directors breached their fiduciary duty to the Company, and an unnamed amount of damages.

Quote: billryan

Those press releases you kept posting were full of obvious lies. Their trials would be a total failure...

I've lost money on hundreds of companies, and lost 85% plus on more than a few...

Three days ago CNN Brazil, where Covid-19 is raging announced that the Brazilian FDA Anvisa has granted phase three trials for Leronlimab.

Are you saying CNN is obviously lying?

Anvisa happens to be known as tougher on drug approval than the US FDA and unlike the FDA, is an independent body (the US FDA is funded by the big pharmaceutical companies it oversees)

Are you saying that Anvisa in Brazil is lying?

https://www.google.com/amp/s/www.cnnbrasil.com.br/amp/saude/2021/08/03/covid-19-anvisa-autoriza-estudo-clinico-com-o-anticorpo-monoclonal-leronlimabe

It's funny you lost 85% of your lifetime investment. It sounds like you don't really know a good investment from that track record. Perhaps that is why you assume everything you read from a company is a lie.

As you noted, there are no current criminal charges against Cytodyn and no halt to trading by the SEC.
Perhaps that should tell you if they really lied to investors.

Quote: darkoz

Three days ago CNN Brazil, where Covid-19 is raging announced that the Brazilian FDA Anvisa has granted phase three trials for Leronlimab.

Are you saying CNN is obviously lying?

Anvisa happens to be known as tougher on drug approval than the US FDA and unlike the FDA, is an independent body (the US FDA is funded by the big pharmaceutical companies it oversees)

Are you saying that Anvisa in Brazil is lying?

https://www.google.com/amp/s/www.cnnbrasil.com.br/amp/saude/2021/08/03/covid-19-anvisa-autoriza-estudo-clinico-com-o-anticorpo-monoclonal-leronlimabe

It's funny you lost 85% of your lifetime investment. It sounds like you don't really know a good investment from that track record. Perhaps that is why you assume everything you read from a company is a lie.

As you noted, there are no current criminal charges against Cytodyn and no halt to trading by the SEC.
Perhaps that should tell you if they really lied to investors.

I lost 85% of my lifetime investment? Either you can't read or you are just making stuff up again. I said I have lost 85% of some investments. I doubt there are many investors who have not done that on a few if they are willing to take risks like I was. You are an utter novice in the market and keep making ridiculous statements like no one tracks a stock they don't own. Now you are asking if CNN is lying for reporting the company has announced yet another trial?

Quote: billryan

Did the ambulance chasing lawyers get half of the former board to sue the company?

On April 24, 2020, certain stockholders of CytoDyn Inc. (the “Company), including two former directors and a company controlled by a former director (Anthony D. Caracciolo of the Caracciolo Family Trust, Gregory A. Gould, and Alpha Venture Capital Partners L.P., controlled by Carl C. Dockery, respectively), filed a derivative stockholder complaint in the Court of Chancery of the State of Delaware, alleging claims for breach of fiduciary duty and unjust enrichment against the Company’s CEO, current and former CFO, CMO, and current and former members of the Company’s board of directors in connection with certain equity grant awards to these individuals in December 2019 and January 2020. The Company disclosed these awards in the Company’s Current Reports on Form 8-K filed with the U.S. Securities and Exchange Commission on December 27, 2019 and February 3, 2020. The Company was named as a nominal defendant. The plaintiffs seek the rescission of the awards, a finding that the named directors breached their fiduciary duty to the Company, and an unnamed amount of damages.

Bill,

Anyone can file a lawsuit because they feel agrieved.

That doesn't prove anything.

You claim Cytodyn has lied to it's investors and point to lawsuits.

I am pointing to:

SEC has not halted trading

DOJ has made no criminal complaint or charges

FDA ran trials and while not approving the drug has NOT rescinded Leronlimab's current OLE status

Brazil Anvisa has just okayed a massive 35 trial site 600+ patient enrollment in phase three trials.

NEJM (New England Journal of Medicine) a peer reviewed medical journal had an article on Leronlimab and it's MOA (mechanism of action)

Bill, you keep pointing to legal issues that in today's litigious atmosphere amount to a hill of beans.

What reason I don't know. You should ask yourself why SEC, DOJ, Anvisa FDA and NEJM don't see what you see.

Quote: billryan

Now you are asking if CNN is lying for reporting the company has announced yet another trial?

That's funny.

It's a simple enough question.

Why can't you answer it?

Quote: darkoz

Bill,

Anyone can file a lawsuit because they feel agrieved.

That doesn't prove anything.

You claim Cytodyn has lied to it's investors and point to lawsuits.

I am pointing to:

SEC has not halted trading

DOJ has made no criminal complaint or charges

FDA ran trials and while not approving the drug has NOT rescinded Leronlimab's current OLE status

Brazil Anvisa has just okayed a massive 35 trial site 600+ patient enrollment in phase three trials.

NEJM (New England Journal of Medicine) a peer reviewed medical journal had an article on Leronlimab and it's MOA (mechanism of action)

Bill, you keep pointing to legal issues that in today's litigious atmosphere amount to a hill of beans.

What reason I don't know. You should ask yourself why SEC, DOJ, Anvisa FDA and NEJM don't see what you see.

It is not anyone suing the company, it is half of the former Board of Directors. While not unprecedented, it is both rare and unusual.

As far as the Brazilian thing, I'd never heard of Anvisa but the very first article I googled when I asked about their reputation had this gem

“Anvisa has been accused of lying, working unethically, and producing fake news on the identification of replicating adenoviruses in documents on the Sputnik V vaccine. The information on the presence of replicating adenoviruses can be found in the documents submitted to Anvisa by the developer of vaccine Sputnik V,” Barra Torres declared.

Sounds like a match made in heaven.

Current and former CytoDyn Inc. board members and executives reached a proposed settlement Thursday of a lawsuit in Delaware Chancery Court claiming they enriched themselves at the expense of public investors through “unjustified and oversized awards” of stock and options.

The agreement, which requires the approval of Vice Chancellor Paul A. Fioravanti Jr., would rescind about 5.4 million of the 9.3 million shares and options CytoDyn’s leaders gave themselves in December 2019, according to the court filing disclosing the deal.


I can copy and paste these all night.

On March 18, 2021, a lawsuit was filed against CytoDyn Inc. over alleged securities laws violations. The plaintiff alleged that the defendants made materially false and/or misleading statements, and failed to disclose that while CytoDyn's stock price was sufficiently pumped with the COVID-19 cure hype, long-term shareholders, including CEO Nader Z. Pourhassan and CFO Michael Mulholland, dumped millions of shares, that CytoDyn engaged in a wrongful scheme with its lender, Iliad Research and Trading L.P. ('Iliad'), and its principal John Fife ('Fife'), whereby Iliad and other Fife entities operated as an unregistered securities dealer for CytoDyn, and that Iliad obtained a convertible promissory note from CytoDyn and converted the note into newly issued shares of CytoDyn and sold those shares into the public market at a profit, in violation of the dealer registration requirements of the federal securities laws.


I can copy and paste these all night.

My thought is that anyone that says they have never bought a stock that lost money is probably a liar.

Quote: billryan

Current and former CytoDyn Inc. board members and executives reached a proposed settlement Thursday of a lawsuit in Delaware Chancery Court claiming they enriched themselves at the expense of public investors through “unjustified and oversized awards” of stock and options.

The agreement, which requires the approval of Vice Chancellor Paul A. Fioravanti Jr., would rescind about 5.4 million of the 9.3 million shares and options CytoDyn’s leaders gave themselves in December 2019, according to the court filing disclosing the deal.


I can copy and paste these all night.

But you can't answer a simple question.

Do you think CNN Brazil is lying?

Quote: darkoz

But you can't answer a simple question.

Do you think CNN Brazil is lying?

I do not know the context of that question, but yes I believe CNN Brazil is lying.

Quote: DRich

I do not know the context of that question, but yes I believe CNN Brazil is lying.

I wasn't asking you DRich but thanks for your support... Not!

CNN, according to you reported yet another trial. Why would I think its not true. It's what this company does. Announce a trial and then when it fails, they lie about it, put out false press releases and grant themselves more options. Rinse and repeat.

Quote: billryan

CNN, according to you reported yet another trial. Why would I think its not true. It's what this company does. Announce a trial and then when it fails, they lie about it, put out false press releases and grant themselves more options. Rinse and repeat.

That makes no sense, really.

They have real trials?

With drug regulatory agencies overlooking the results?

You just have a problem when the trial doesn't pass stringent regulatory processes? You feel that the company was lying? You feel success should have been guaranteed by the company?

And what do you mean "CNN, according to you, reported"? I supplied a link to the article so for you to word it like that makes it sound like I am lying.

In India we're all the rave
Discovered that it's great as aftershave, oh-ho
Dropped in the sea just off Japan
Swapped twenty bottles for an aqua-walkman, oh
Immunity from ridicule
Improves your brains if you're a fool, oh-ho
And I read in the Middle East
Traded some for a hostage release
Now if you're bald it'll give you hair
If you've got straight trousers it'll give you flares
Feeling up you'll get depressed
Out of style here's a brand new dress, oh
It was really vile weather
When we got tarred and feathered
You could hear the six-guns sound
As they chased us out of town

Quote: darkoz

That makes no sense, really.

They have real trials?

With drug regulatory agencies overlooking the results?

You just have a problem when the trial doesn't pass stringent regulatory processes? You feel that the company was lying? You feel success should have been guaranteed by the company?

And what do you mean "CNN, according to you, reported"? I supplied a link to the article so for you to word it like that makes it sound like I am lying.

This is the article you linked. I don't speak Portuguese. Do you?


A farmacêutica Biomm informou nesta segunda-feira (2) que recebeu autorização da Agência Nacional de Vigilância Sanitária (Anvisa) para iniciar o estudo clínico de fase 3 do anticorpo monoclonal leronlimabe no Brasil contra a covid-19.

De acordo com o CEO da companhia, Heraldo Marchezini, os testes ajudam a esclarecer as informações necessárias para encontrar uma nova alternativa no tratamento da covid-19 em pacientes internados.

ADVERTISING

Leia mais
Covid-19: EUA autorizam uso emergencial de tratamento com anticorpo monoclonal
Anvisa aprova uso emergencial de novo coquetel de anticorpos contra Covid-19
Anvisa tem 90 medicamentos em lista de ensaio clínico para tratamento da Covid
A investigação será realizada em 35 centros de pesquisa com 612 pacientes que se encontram hospitalizados e com necessidade de suporte para oxigenação. O objetivo do medicamento, segundo a farmacêutica, é impedir que a doença evolua para um caso mais grave, com necessidade de ventilação mecânica invasiva.

O leronlimab age para prevenir uma resposta excessiva do sistema imunológico de pacientes infectados com o novo coronavírus, reduzindo a superprodução de citocinas inflamatórias, também conhecidas como "tempestade de citocinas". "Esta tempestade inflamatória, que agrava a condição clínica significativamente, pode, muitas vezes, levar o paciente a óbito", declara a Biomm.

O ensaio clínico será conduzido pela Academic Research Organization (ARO) do Hospital Israelita Albert Einstein (HIAE), em colaboração com a CytoDyn, empresa americana responsável pelo desenvolvimento do medicamento, e a Biomm, parceira exclusiva para a comercialização do leronlimab no Brasil.



Tópicos

Covid-19
MAIS LIDAS NA CNN
1
STJ concede habeas corpus e solta suspeito de atear fogo ao Borba Gato
2
Presidente Bolsonaro só vira réu se denúncia passar pela Câmara, diz professor
3
Veja como votaram os deputados na comissão do voto impresso
4
PEC do Voto Impresso vai para votação em comissão: entenda mudanças propostas
5
Tandara é suspensa por potencial violação antidoping e está fora das Olimpíadas
6
Fux decidiu sobre discurso contra Bolsonaro após conversa com Moraes
7
Comissão especial da Câmara rejeita PEC do Voto Impresso
8
Com Selic a 5,25%, quanto rende investir R$ 1.000 em poupança, Tesouro ou fundo
9
Exército sinaliza ao governo que não apoiará rupturas
10
Taxa de embarque de contêineres da China aos EUA supera US$ 20 mil, novo recorde

Quote: billryan

In India we're all the rave
Discovered that it's great as aftershave, oh-ho
Dropped in the sea just off Japan
Swapped twenty bottles for an aqua-walkman, oh
Immunity from ridicule
Improves your brains if you're a fool, oh-ho
And I read in the Middle East
Traded some for a hostage release
Now if you're bald it'll give you hair
If you've got straight trousers it'll give you flares
Feeling up you'll get depressed
Out of style here's a brand new dress, oh
It was really vile weather
When we got tarred and feathered
You could hear the six-guns sound
As they chased us out of town

Wow,

So you have given up arguing and.are just posting unrelated song lyrics or Robert Frost poems or whatever that is.

I guess you realize you were not correct about Cytodyn

Dark Oz sys this:

"No, There are some. I don't see any merit in the lawsuits and I suspect they aren't going anywhere.

My point is those law firms are ambulance chasing.

By the time those are settled (years from now) the Leronlimab trials will be over and the stock price will hopefully have soared. Anyone who sold at a loss and is suing is just a bad investor."

When reality shows this:
Current and former CytoDyn Inc. board members and executives reached a proposed settlement Thursday of a lawsuit in Delaware Chancery Court claiming they enriched themselves at the expense of public investors through “unjustified and oversized awards” of stock and options.

The agreement, which requires the approval of Vice Chancellor Paul A. Fioravanti Jr., would rescind about 5.4 million of the 9.3 million shares and options CytoDyn’s leaders gave themselves in December 2019, according to the court filing disclosing the deal.

Quote: billryan

Dark Oz sys this:

"No, There are some. I don't see any merit in the lawsuits and I suspect they aren't going anywhere.

My point is those law firms are ambulance chasing.

By the time those are settled (years from now) the Leronlimab trials will be over and the stock price will hopefully have soared. Anyone who sold at a loss and is suing is just a bad investor."

When reality shows this:
Current and former CytoDyn Inc. board members and executives reached a proposed settlement Thursday of a lawsuit in Delaware Chancery Court claiming they enriched themselves at the expense of public investors through “unjustified and oversized awards” of stock and options.

The agreement, which requires the approval of Vice Chancellor Paul A. Fioravanti Jr., would rescind about 5.4 million of the 9.3 million shares and options CytoDyn’s leaders gave themselves in December 2019, according to the court filing disclosing the deal.

Are you unable to differentiate between lawsuits by investors (your original statements referred to those) and lawsuit's filed years ago by former employees?

From the Annual Report:

Quote:

• Our auditors have issued a going concern opinion, and we will not be able to achieve our objectives and will have to cease operations if we cannot find adequate financing.
• We are a clinical stage biotechnology company with a history of significant operating losses; we expect to continue to incur operating losses, and we may never achieve, let alone maintain, profitability.

Nice! Sounds promising.

https://seekingalpha.com/filing/5643361

And:

Quote:

Our auditors issued an opinion, which includes a going concern exception, in connection with the audit of our annual financial statements for the fiscal year ended May 31, 2021. A going concern exception to an audit opinion means that there is substantial doubt that we can continue as an ongoing business for the next 12 months. If we are unable to continue as a going concern, we might have to liquidate our assets and the values we receive for our assets in liquidation or dissolution could be significantly lower than the values reflected in our financial statements. In addition, the inclusion of an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern and our lack of cash resources may materially adversely affect our share price and our ability to raise new capital or to enter into critical contractual relations with third parties. There is no assurance that we will be able to adequately fund our operations in the future.

Same source.

Quote: darkoz

Are you unable to differentiate between lawsuits by investors (your original statements referred to those) and lawsuit's filed years ago by former employees?

The lawsuit in question was filed in April or May of 2020. What month was it you proclaimed this was the cure for covid?

Quote: Mission146

From the Annual Report:



Nice! Sounds promising.

https://seekingalpha.com/filing/5643361

Haterz

Quote: Mission146

And:



Same source.

More haterz

It’s probably true of most penny stocks, but Biotech penny stocks are like walking into a room with 200 blindfolded guys throwing darts at boards and trying to bet on which one will hit a bullseye first.

Quote: billryan

Haterz

ThumbTackerz ?
$:o)

Quote: billryan

Haterz

ThumbTackerz ?

Quote: billryan

More haterz

More ThumbTackerz ?
$:o)

Billy….. you have done a lot of research on CYDY. Frankly, maybe I should have done as much as you before I plopped down my $1.6k! Is it possible to short CYDY? Have you considered it?

OnceDear…. Would it be appropriate to break this conversation off into its own thread?

Quote: SOOPOO

OnceDear…. Would it be appropriate to break this conversation off into its own thread?

Possibly, But then I'd be inclined to direct MDawg, DO and other interested parties to keep it in that thread.
One for the new mods to consider.

Quote: billryan

The lawsuit in question was filed in April or May of 2020. What month was it you proclaimed this was the cure for covid?

Vancouver, Washington
Early 2020 A.D.

The CEO sat in the office and grimaced at his laptop. He'd spent so much time on Pornhub in the last several years that he was pretty sure he'd seen literally every video at this point. The company wasn't doing so hot as the pharmaceutical product, LemonLamb, hadn't been performing terribly well in treating HIV or Cancer. Consequently, he was having tremendous difficulty getting excited by the material. He gave himself a shot of Lemonlamb, figuring it probably also works for erectile dysfunction.

Of course, the company did have one angle---the fact that it is an intravenous treatment, so they could at least tout the fact that people suffering from...well, whatever LemonLamb might happen to help, if anything...wouldn't have to remember to take their pills.

An assistant walked into the room, "Good morning, boss. Any good news from the clinical phases yesterday?"

The CEO hurriedly closed his laptop and slurped up some of last night's Lo Mein from his take out box, still chewing he said, "Mmm-mmm...nom...um...nom...Nothing really. Actually, I don't have the report yet. I'll get it as soon as we can get approved for a loan and get the internet turned back on where it's being tested."

The CEO's top assistant knew that this company was a disaster, but since he was from a temp agency, he had no choice on where he went. He looked up at the CEO and asked, "Is there anything I can do for you, sir?"

The CEO inquired, "Do you know plumbing?"

The assistant cocked his head, "Like, how to be a plumber?"

The CEO responded, "Yeah, the water won't run into the tank of the toilet in my office. I don't know how to fix that. I'd have to flood the market with at least 200,000 newly issued common shares to be able to afford a plumber and you know those ******* at the SEC would **** themselves if I did that."

Bewildered, the assistant said, "The tanks won't fill anywhere in the building. They shut the water off last month."

"Damn," the CEO muttered, "Okay, well, I have an important mission for you young man!"

The assistant brightened, it had been about a month since he actually had an assignment that he'd imagine the assistant to a Biotech CEO should be doing, "What's that?"

The CEO leaned in and whispered, "I need you to go down to the Chevron, ask to use the public restroom, but get the key and don't give it back to them. Bring it here! We will have our new corporate bathroom!"

At that moment, the assistant's phone buzzed and he checked his messages and replied. The CEO was looking a bit testy, so the assistant offered, "Sorry, my wife was getting tested today. The good news is that she's negative."

"Tested?" The CEO asked, "It wasn't for AIDS or Triple Negative Breast Cancer, was it? We know how to cure those. I think it works on Syphilis and Strep Throat, also."

The assistant chuckled, "No, it was for Covid-19, Coronavirus."

The CEO cocked an eyebrow, "What the hell is a Coronavirus?"

The assistant responded, mouth agape, "You're the CEO of a...oh, never mind. It's a viral variant that attacks the respiratory system and is easily transmissible. It looks like this is legitimately going to be a worldwide pandemic. You haven't heard of it?"

"Easily transmissible?"

"That means it's contagious," the assistant offered.

"Contagious, you say...hmmm," the CEO's brows furrowed, and after a few seconds, his eyes bulged, "USE LEMONLAMB ON IT!!!"

The assistant was confused, "You want us to try to use the drug that we have been testing primarily for AIDS treatment...on the Coronavirus?"

"Listen, boy, I know you're a little green, but the most important part of marketing is that you have to believe in your product!" The CEO straightened his tie, checked his teeth in the mirror, and continued, "If we can just get those nancy-boys at the FDA to approve it, we can push this thing hard. This is going to be huge. LemonLamb---The Cure to Coronavirus, and also AIDS, of course."

Shocked, the assistant responded, "That's like saying you can take Gaviscon for Parkinson's! How do you know that LemonLamb and the Coronavirus have anything to do with each other?"

"No," the CEO intoned, "The question is: how do you know that they don't?"

The assistant admitted, "Well, I guess I don't KNOW that they don't."

"Which means that they probably do. Put out a press release---LemonLamb cures Coronavirus!"

"Are we calling it Lemonlamb," the assistant asked, "Up until now, we have called it Leronlimab."

"Oh, that's a stupid name. Oh well. We'll stay with it."

Quote: SOOPOO

Billy….. you have done a lot of research on CYDY. Frankly, maybe I should have done as much as you before I plopped down my $1.6k! Is it possible to short CYDY? Have you considered it?

OnceDear…. Would it be appropriate to break this conversation off into its own thread?

Of course it’s possible to short it. It has had one of the highest short interests in the market in recent months. Good luck locating a borrow, though!

Quote: SOOPOO

Billy….. you have done a lot of research on CYDY. Frankly, maybe I should have done as much as you before I plopped down my $1.6k! Is it possible to short CYDY? Have you considered it?

OnceDear…. Would it be appropriate to break this conversation off into its own thread?

Quote: Mission146

Vancouver, Washington
Early 2020 A.D.

The CEO sat in the office and grimaced at his laptop. He'd spent so much time on Pornhub in the last several years that he was pretty sure he'd seen literally every video at this point. The company wasn't doing so hot as the pharmaceutical product, LemonLamb, hadn't been performing terribly well in treating HIV or Cancer. Consequently, he was having tremendous difficulty getting excited by the material. He gave himself a shot of Lemonlamb, figuring it probably also works for erectile dysfunction.

Of course, the company did have one angle---the fact that it is an intravenous treatment, so they could at least tout the fact that people suffering from...well, whatever LemonLamb might happen to help, if anything...wouldn't have to remember to take their pills.

An assistant walked into the room, "Good morning, boss. Any good news from the clinical phases yesterday?"

The CEO hurriedly closed his laptop and slurped up some of last night's Lo Mein from his take out box, still chewing he said, "Mmm-mmm...nom...um...nom...Nothing really. Actually, I don't have the report yet. I'll get it as soon as we can get approved for a loan and get the internet turned back on where it's being tested."

The CEO's top assistant knew that this company was a disaster, but since he was from a temp agency, he had no choice on where he went. He looked up at the CEO and asked, "Is there anything I can do for you, sir?"

The CEO inquired, "Do you know plumbing?"

The assistant cocked his head, "Like, how to be a plumber?"

The CEO responded, "Yeah, the water won't run into the tank of the toilet in my office. I don't know how to fix that. I'd have to flood the market with at least 200,000 newly issued common shares to be able to afford a plumber and you know those ******* at the SEC would **** themselves if I did that."

Bewildered, the assistant said, "The tanks won't fill anywhere in the building. They shut the water off last month."

"Damn," the CEO muttered, "Okay, well, I have an important mission for you young man!"

The assistant brightened, it had been about a month since he actually had an assignment that he'd imagine the assistant to a Biotech CEO should be doing, "What's that?"

The CEO leaned in and whispered, "I need you to go down to the Chevron, ask to use the public restroom, but get the key and don't give it back to them. Bring it here! We will have our new corporate bathroom!"

At that moment, the assistant's phone buzzed and he checked his messages and replied. The CEO was looking a bit testy, so the assistant offered, "Sorry, my wife was getting tested today. The good news is that she's negative."

"Tested?" The CEO asked, "It wasn't for AIDS or Triple Negative Breast Cancer, was it? We know how to cure those. I think it works on Syphilis and Strep Throat, also."

The assistant chuckled, "No, it was for Covid-19, Coronavirus."

The CEO cocked an eyebrow, "What the hell is a Coronavirus?"

The assistant responded, mouth agape, "You're the CEO of a...oh, never mind. It's a viral variant that attacks the respiratory system and is easily transmissible. It looks like this is legitimately going to be a worldwide pandemic. You haven't heard of it?"

"Easily transmissible?"

"That means it's contagious," the assistant offered.

"Contagious, you say...hmmm," the CEO's brows furrowed, and after a few seconds, his eyes bulged, "USE LEMONLAMB ON IT!!!"

The assistant was confused, "You want us to try to use the drug that we have been testing primarily for AIDS treatment...on the Coronavirus?"

"Listen, boy, I know you're a little green, but the most important part of marketing is that you have to believe in your product!" The CEO straightened his tie, checked his teeth in the mirror, and continued, "If we can just get those nancy-boys at the FDA to approve it, we can push this thing hard. This is going to be huge. LemonLamb---The Cure to Coronavirus, and also AIDS, of course."

Shocked, the assistant responded, "That's like saying you can take Gaviscon for Parkinson's! How do you know that LemonLamb and the Coronavirus have anything to do with each other?"

"No," the CEO intoned, "The question is: how do you know that they don't?"

The assistant admitted, "Well, I guess I don't KNOW that they don't."

"Which means that they probably do. Put out a press release---LemonLamb cures Coronavirus!"

"Are we calling it Lemonlamb," the assistant asked, "Up until now, we have called it Leronlimab."

"Oh, that's a stupid name. Oh well. We'll stay with it."

This story sounds made up to me. Nobody could actually believe they have seen every video on Pornhub.

Quote: DRich

This story sounds made up to me. Nobody could actually believe they have seen every video on Pornhub.

How many are there? I went with the site that I know the name of!

Quote: Mission146

How many are there? I went with the site that I know the name of!

Xvideos seems to avoid malware.

I would stay away from pornhub.